Marijuana Policy Project founder Rob Kampia is no longer employed by or serves on the board of the organization.
He is starting a new cannabis policy group called Marijuana Leadership Campaign (MLC), structured as a for-profit LLC consulting firm.
The new company “will focus almost exclusively on changing U.S. laws,” Kampia said in a relatively unusual memo shared with Marijuana Moment late Saturday night, which also says that the firm has lined up “nearly $500,000 in seed money” from “a marijuana investment firm in Los Angeles, a major marijuana dispensary in Colorado, Kampia’s wealthy friends in Texas (where he lives half-time) and a coalition of new donors in South Carolina.”
The split with MPP is occurring as greater attention is being paid to past allegations of sexual misconduct by Kampia amidst a national backlash against workplace sexual harassment and abuse.
In 2010, a lengthy Washington City Paper story reported that Kampia had sex with an intoxicated MPP employee, an incident after which a staff revolt nearly led to his ouster from the organization. He later took a leave of absence to seek therapy, telling the Washington Post that he was “hypersexualized.”
Now, Kampia’s departure from MPP comes as several sources tell Marijuana Moment that a major newspaper is working on a story about previously unreported allegations against the former executive director. It is unknown when that article will be published, but its existence has been an open secret in cannabis reform circles for weeks.
Formally leaving the organization is the second and final wave in Kampia’s diminishing role at MPP, which he co-founded in 1995.
In November, days before Thanksgiving, MPP announced that Kampia had stepped down from his role as executive director but would remain at the organization in a new capacity focused on fundraising and strategy.
The new memo, shared with Marijuana Moment just before midnight on the day before Christmas Eve, says that the first announcement “opened new business opportunities for Kampia” and that while he “initially proposed splitting his time equally between MPP and the new MLC, Kampia and his fellow MPP board members reached a second milestone by voting unanimously on Dec. 20 to end his full-time status at MPP this weekend.”
It was also revealed this week that Kampia is no longer a member of Students for Sensible Drug Policy’s Advisory Council. Kampia said in an interview with Marijuana Moment on Sunday that he remains a member of the National Cannabis Industry Association (NCIA) board of directors.
The memo appears to lay out the case that Kampia’s departure from MPP has nothing to do with any old or new allegations of sexual misconduct, and he said in the interview that conversations among the organization’s board “about me shifting into lesser roles at MPP extend all the way back into late October.”
“We didn’t even talk about the s-word at all,” he said, referring to sex. “It wasn’t even on our minds, which I think was kind of naive of us given the stuff that’s happening with all of these celebrities.”
But Kampia acknowledged in the interview that he “did know that there was a story in the works somewhere” at the time he registered the domain name www.marijuanaleadershipcampaign.com on December 5.
“I didn’t know which publication. I didn’t know any of the questions. I didn’t know the name of the reporter. I didn’t know anything,” he said. “I just knew that people were sort of talking about how there’s a story in the works.”
Kampia has been a key architect of many of the most significant marijuana policy victories over the past two decades, and has arguably been the legalization movement’s best fundraiser.
In the memo, he says that MLC “will work alongside the institutions he views as most effective in each sector” of the movement and industry. While the document names MPP, NCIA and New Federalism Fund as “leading the charge,” and says that the new company will “provide substantial funding” for Doctors for Cannabis Regulation (DFCR), the Law Enforcement Action Partnership (LEAP) and Clergy for a New Drug Policy, Kampia said in the interview that he hasn’t “cleared the fact that I want to give them money” with those groups.
LEAP and DFCR did not respond to requests for comment.
The memo says Kampia will divide his time between work on Texas, South Carolina, Michigan and congressional cannabis policy reform efforts as well as “raising money to make MDMA (known as ‘Ecstasy’) available as a prescription medicine for the treatment of PTSD and end-of-life anxiety.”
He plans to raise more than $2 million in 2018 from steering committees comprised of donors contributing at least $100,000 each.
When asked if the investors who have already committed nearly half a million dollars to the new venture are aware of the looming newspaper story on sexual misconduct allegations, Kampia said that “they know about the worst allegations that have ever been made about me, and I have no reason to believe that the [newspaper] story will be worse than that, so these guys are friends of the family and they’re not going to be surprised by anything in the [newspaper] and in fact they might be pleasantly surprised.”
Several of the projects mentioned in the MLC document are campaigns that Kampia had been raising money to support through MPP, but he rejected the idea that his outside efforts would drain the nonprofit of resources.
“Are there people that want to fund Texas where they might otherwise be nervous about writing a check to MPP, where they might have to pay for payroll for Rhode Island, Vermont and the national operation?” he asked, suggesting that his new outfit would be “value-added” rather than competition.
“One thing for sure that no one would do if not for the fact that I’m going to agitate for it, is to take out Congressman Pete Sessions,” he said, referring to the Republican House Rules Committee chairman who has consistently blocked marijuana amendments from being voted on. “Take out, meaning not to date him,” he said, but to un-elect him.
In the memo, Kampia twice offers quotes that he suggests are in jest, at least in part.
In the first instance, he jokes that working full-time for nonprofit organizations is “a good way to avoid amassing wealth,” while working on marijuana policy reform through an LLC will allow him to form business relationships with for-profit institutions.
Kampia, who owns a Washington, D.C,. row house that he has often referred to as “The Purple Mansion,” dismissed concerns that people might take offense to his quip about amassing wealth.
“It depends on what your definition of wealth is. I don’t have cash,” he said in the interview. “All my money goes into my mortgage. So you could say that I have wealth or not, depending on your perspective. I don’t mind if that offends people or not, because socialists who are averse to wealth probably already hate me.”
He also “half-jokingly” wrote that he hopes “to be standing behind President Rand Paul during his bill-signing ceremony [for ‘the ultimate bill to legalize marijuana on the federal level’] in the White House in 2022.”
“I don’t think Trump is going to survive reelection,” he said when asked what Paul’s path to the presidency in the 2020 election would be. “I would like to see [Trump] impeached…and I think Mike Pence is tainted as a result of being in bed with Trump. So I think that you are going to see a bunch of challengers… Rand Paul was obviously my favorite candidate last time around and so I’m cheering him on. I don’t have any inside knowledge, though. I haven’t talked to him personally.”
The memo mentions Kampia’s holiday vacation plans in the Caribbean and says that when he returns to the country the new organization will hold a series of leadership meetings in Austin, Dallas and Washington, D.C.
He will also write a book that “provides an insider’s look at the marijuana-legalization movement.” He told Marijuana Moment that the working title is, “How We Legalized Marijuana.”
The memo offers a very specific account of the book’s progress to date.
“I’m particularly excited about writing my book, which will be nonfiction but will oftentimes read like fiction, as my life is strewn with outrageous experiences that are sometimes relevant to readers who have an interest in politics generally and marijuana policy specifically,” Kampia wrote. “The book is already one-eighth written, and I’m planning to spend my time in the Bahamas and other sunny islands writing another three- eighths of the book. In fact, one reason I’m leaving MPP is to write this book, with an aggressive book tour planned for the fall of 2018.”
An MPP communications staffer could not be reached for comment by publication time, but a board member who did not wish to be named said, “I can confirm that we have been negotiating his permanent separation from the org for weeks and that he is no longer conducting any MPP business.”
Read Kampia’s full three-page memo on the new firm below:
Photo courtesy of ReasonTV.
UN Committee Unexpectedly Withholds Marijuana Scheduling Recommendations
On Friday, the World Health Organization (WHO) was expected to make recommendations about the international legal status of marijuana, which reform advocates hoped would include a call to deschedule the plant and free up member countries to pursue legalization.
But in a surprise twist, a representative from the organization announced that WHO, a specialized agency of the United Nations, would be temporarily withholding the results of its cannabis assessment, even as it released recommendations on an opioid painkiller and synthetic cannabinoids. The marijuana recommendations are now expected to come out in January.
Earlier this year, the WHO Expert Committee on Drug Dependence (ECDD) released a pre-review of marijuana that included several positive, evidentiary findings. Cannabis has never caused a fatal overdose, the committee said, and research demonstrates that ingredients in the plant can effectively treat pain and improve sleep, for example.
The pre-review results prompted a more in-depth critical review, one of the final stages before the UN’s Commission on Narcotic Drugs (CND) makes a determination about whether marijuana should remain in the most restrictive international drug classification. But on Friday, as observers anxiously awaited that determination, WHO pumped the brakes. The committee said it needed more time “for clearance reasons,” according to the International Drug Policy Consortium.
The @WHO's Expert Committee on Drug Dependence met in November to discuss the scheduling of cannabis and related/other substances.
— IDPC (@IDPCnet) December 7, 2018
“This decision to withhold the results of the critical review of cannabis appears to be politically motivated,” Michael Krawitz, a U.S. Air Force veteran and legalization advocate who has pushed for international reform, said in a press release.
“The WHO has been answering many questions about cannabis legalization, which is not within their mandate. I hope the WHO shows courage and stands behind their work on cannabis, findings we expect to be positive based upon recent WHO statements and their other actions today.”
Those other actions include recommending that the opioid painkiller tramadol should not be scheduled under international treaties out of concern that such restrictions would limit access and hurt patients. In August, the committee made a similar recommendation about pure cannabidiol, or CBD, a component of marijuana.
While the critical review of marijuana itself has been postponed, the committee’s recommendations for its international scheduling are still expected to go up for a vote in the CND in March. If the committee does decide to recommend that cannabis be removed from international control, that would have wide-ranging implications for the reform efforts around the world.
In the U.S., the federal government has routinely cited obligations under international treaties to which it is a party as reasons to continue to ban marijuana and its derivatives. For instance, the Food and Drug Administration said in May that CBD doesn’t meet the criteria for federal scheduling at all, but that international treaties obliged it to recommend rescheduling to Schedule V.
“If treaty obligations do not require control of CBD, or if the international controls on CBD change in the future, this recommendation will need to be promptly revisited,” the agency said.
Where Trump’s Pick For Attorney General Stands On Drug Policy
President Donald Trump said on Friday that he plans to nominate William Barr to replace Jeff Sessions as U.S. attorney general.
Barr, who previously served in the position under President George H. W. Bush’s administration, seems less openly hostile to marijuana compared to other potential nominees whose names were floated—like New Jersey Gov. Chris Christie (R), who pledged to crack down on state-legal cannabis activity during his failed 2016 presidential bid.
That said, he developed a reputation as anti-drug while overseeing harsh enforcement policies under Bush.
….and one of the most highly respected lawyers and legal minds in the Country, he will be a great addition to our team. I look forward to having him join our very successful Administration!
— Donald J. Trump (@realDonaldTrump) December 7, 2018
The prospective nominee seems to share a worldview with the late president under whom he served. Bush called for “more prisons, more jails, more courts, more prosecutors” to combat drug use and dramatically increased the federal drug control budget to accomplish that goal. In 1992, Barr sanctioned a report that made the “case for more incarceration” as a means to reduce violent crime.
Barr wrote a letter explaining why he was releasing the report, which has now resurfaced as observers attempt to gauge how he will approach drug policy in the 21st century.
“[T]here is no better way to reduce crime than to identify, target, and incapacitate those hardened criminals who commit staggering numbers of violent crimes whenever they are on the streets,” he wrote. “Of course, we cannot incapacitate these criminals unless we build sufficient prison and jail space to house them.”
“Revolving-door justice resulting from inadequate prison and jail space breeds disrespect for the law and places our citizens at risk, unnecessarily, of becoming victims of violent crime.”
He also wrote a letter to lawmakers in 2015 defending the criminal justice system—including mandatory minimum sentences—and encouraging Congress not to bring up a sentencing reform bill.
“It’s hard to imagine an Attorney General as bad as Jeff Sessions when it comes to criminal justice and the drug war, but Trump seems to have found one,” Michael Collins, director of national drug affairs for the Drug Policy Alliance, said in a press release. “Nominating Barr totally undermines Trump’s recent endorsement of sentencing reform.”
“The vast majority of Americans believe the war on drugs needs to be replaced with a health-centered approach. It is critically important that the next Attorney General be committed to defending basic rights and moving away from failed drug war policies. William Barr is a disastrous choice.”
Another window into Barr’s criminal justice perspective comes from 1989, when he wrote a Justice Department memo that authorized the FBI to apprehend suspected fugitives living in other countries and extradite them to the U.S. without first getting permission from the country. The intent of the memo seemed to be to enable the U.S. to more easily capture international drug traffickers.
In 2002, Barr compared drug trafficking to terrorism and described the drug war as the “biggest frustration” he faced under Bush. The administration “did a very good job putting in place the building blocks for intelligence building and international cooperation, but we never tightened the noose,” he said.
Interestingly, as The Washington Post reported, Barr would be heading up a department where his daughter, Mary Daly, also works. Daly is the director of opioid enforcement and prevention efforts in the deputy attorney general’s office, and she’s established herself as an advocate for tougher criminal enforcement aimed at driving out the opioid epidemic.
Today’s drug policy landscape is a lot different than it was in the early 1990s, though, and it’s yet to be seen how Barr, if confirmed by the Senate, will navigate conflicting state and federal marijuana laws. He’ll also be inheriting a Justice Department that no longer operates under an Obama-era policy of general non-intervention, after Sessions moved this year to rescind the so-called Cole memo that provided guidance on federal cannabis enforcement.
But for advocates, at least it’s not the guy who said “good people don’t smoke marijuana” anymore and it won’t be one who campaigned for president saying he’d enforce federal prohibition in legal states, either.
Marijuana Bills Are Already Being Pre-Filed For 2019 Legislative Sessions
If you thought 2018 was a big year for marijuana, gear up for 2019. Before the next legislative session has even started, lawmakers in at least four states have already pre-filed a wide range of cannabis reform bills.
In Missouri, where voters approved a medical marijuana initiative during last month’s midterm election, a state lawmaker has already drafted a piece of legislation that would legalize cannabis for adult-use—though it would not establish a retail sales system. Instead, adults 21 and older would be allowed to possess up to two ounces of marijuana and grow up to six plants.
At least one marijuana decriminalization bill will be on the table in Virginia next year. The legislation would reduce the penalty for simple possession from a misdemeanor offense punishable by a maximum of a $500 fine and up to 30 days in jail to a civil penalty punishable by a $50 fine for first-time offenders, $100 for second-time offenders and $250 for subsequent offenses.
Marijuana Moment is currently tracking more than 900 cannabis bills in state legislatures and Congress. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
Down in Texas, lawmakers in the state House and Senate have already pre-filed no fewer than 12 marijuana-related bills. The legislative proposals range from constitutional amendments to fully legalize and regulate cannabis to simple decriminalization policies to lessen penalties for low-level possession.
Finally, in Nevada, where cannabis is legal for adults, lawmakers have introduced a flurry of what are called “bill draft requests” that relate to marijuana. Proposals to revise cannabis tax policies, create a state bank that could potentially service the legal industry and regulate hemp cultivation—among several others—could be taken up by the state legislature next year.
While the pre-filing process has already started in most states, there’s still time and it’s possible that more cannabis legislation will be introduced for consideration in coming days and weeks prior to the formal start of 2019 legislative sessions.